Prosecution Insights
Prosecution Insights
Tech Center 1700 • Art Units: 1600 1611 1634 1643 1773
This examiner grants 25% of resolved cases
Examiner KATRIEL BARCELLANO KASAYAN is assigned to Tech Center 1700 and Art Unit 1600. The examiner has 4 resolved cases, which provides an initial view into the prosecution environment for this docket. These 4 resolved cases establish a preliminary set of metrics that may fluctuate as the examiner's docket grows.
The allowance rate is 25.0 percent. This 25.0 percent rate indicates the proportion of the 4 resolved cases that resulted in a patent grant. The interview lift is 0.0 percent, suggesting that interviews have not yet shown a statistical impact on the likelihood of success compared to the 25.0 percent baseline. Practitioners should monitor how this 0.0 percent lift develops as more cases reach a final disposition in Art Unit 1600.
The median days to allowance is 1207. This 1207 day timeframe is the median duration for applications that have successfully reached allowance. The 25.0 percent allowance rate and the 1207 day median provide the current benchmarks for Tech Center 1700. Applicants should be aware that these metrics are based on a small sample of 4 resolved cases.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17802686 | COMPOSITIONS, METHODS, KITS, AND SYSTEMS RELATING TO CHARGE-NEUTRAL MICROGELS FOR 3D CELL CULTURE AND PRINTING | Non-Final OA | University of Florida Research Foundation, Inc. |
| 18292483 | Methods of Improving Therapeutic Efficacy of Mesenchymal Stromal Cells for Treatment of Osteoarthritis | Non-Final OA | Emory University |
| 18750595 | METHOD OF CULTURING THREE-DIMENSIONAL CELLULAR TISSUES | Non-Final OA | TOPPAN HOLDINGS INC. |
| 17308462 | COMPOSITIONS AND METHODS RELATING TO REVERSIBLY COMPRESSIBLE TISSUE-HYDROGEL HYBRIDS | Final Rejection | Massachusetts Institute of Technology |
| 18845476 | INDUCED TOTIPOTENT POTENTIAL STEM CELLS, METHODS OF MAKING AND USING | Non-Final OA | Peking University |
| 18838347 | NEURAL PROGENITOR CELL COMPOSITIONS AND METHODS OF USING THE SAME | Non-Final OA | The General Hospital Corporation |
| 17285908 | COMPOSITIONS FOR AND METHODS OF PRODUCING TUMOR ORGANOIDS | Non-Final OA | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM |
| 18014850 | TDP-43 BIOSENSOR CELL LINES | Final Rejection | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM |
| 18265796 | METHODS OF INDUCING AN IMMUNOMODULATORY TUMOR RESPONSE | Non-Final OA | CORNELL UNIVERSITY |
| 18341700 | MATERIALS AND METHODS FOR PRODUCING BLOOD PRODUCTS | Non-Final OA | Cellphire, Inc. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy